Dupont Capital Management Corp reduces its stake in Bath & Body Works, Inc. (NYSE: BBWI)

Dupont Capital Management Corp reduced its stake in shares of Bath & Body Works, Inc. (NYSE: BBWIGet a rating) by 85.6% during the 3rd quarter, according to its last filing with the Securities and Exchange Commission (SEC). The company held 1,652 shares of the company after selling 9,821 shares during the quarter. Dupont Capital Management Corp’s holdings in Bath & Body Works were worth $54,000 when it last filed with the Securities and Exchange Commission (SEC).

→ Huge upside potential with “breathtaking” solar demand (Taken from Investment Trends)

A number of other institutional investors have also been buying and selling stocks recently. Renaissance Technologies LLC increased its holdings of Bath & Body Works stock by 114.0% in Q2. Renaissance Technologies LLC now owns 3,778,033 shares of the company valued at $101,705,000 after purchasing an additional 2,012,700 shares last quarter. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Bath & Body Works during the second quarter valued at approximately $36,823,000. Bank of America Corp DE increased its position in Bath & Body Works shares by 238.2% in Q1. Bank of America Corp DE now owns 1,666,150 shares of the company worth $79,641,000 after buying an additional 1,173,487 shares last quarter. Rezny Wealth Management Inc. increased its stake in shares of Bath & Body Works by 2,300.0% in Q2. Rezny Wealth Management Inc. now owns 840,000 shares of the company worth $25,953,000 after purchasing an additional 805,000 shares last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in Bath & Body Works by 34.5% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,830,984 shares of the company valued at $135,321,000 after purchasing an additional 726,384 shares last quarter. 96.34% of the shares are held by institutional investors.

Bath & Body Works price performance

BBWI opened at $44.25 on Friday. The company has a 50-day simple moving average of $41.94 and a two-hundred-day simple moving average of $37.26. The company has a market capitalization of $10.11 billion, a P/E ratio of 11.52, a PEG ratio of 1.02 and a beta of 1.67. Bath & Body Works, Inc. has a 1 year minimum of $25.75 and a 1 year maximum of $62.26.

Bath and body care (NYSE: BBWIGet a rating) last reported results on Wednesday, November 16. The company reported earnings per share of $0.40 for the quarter, beating consensus analyst estimates of $0.19 from $0.21. The company posted revenue of $1.60 billion for the quarter, versus $1.56 billion expected by analysts. Bath & Body Works had a net margin of 12.48% and a negative return on equity of 40.90%. Stock analysts expect Bath & Body Works, Inc. to post earnings per share of 3.15 for the current year.

Bath & Body Works announces dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 2. Investors of record on Friday, November 18 received a dividend of $0.20 per share. This represents an annualized dividend of $0.80 and a dividend yield of 1.81%. The ex-dividend date was Thursday, November 17. Bath & Body Works’ dividend payout ratio is currently 20.83%.

Analysts set new price targets

BBWI has been the subject of a number of recent research reports. Barclays reduced its target price on Bath & Body Works to $39.00 in a Monday, November 21 research note. Wells Fargo & Company cut shares of Bath & Body Works from an “overweight” rating to an “equal weight” rating and lowered its target price for the stock from $55.00 to $46.00 in a report Friday, January 6. Piper Sandler raised her target price on Bath & Body Works shares from $50.00 to $52.00 in a Tuesday, January 3, research note. Citigroup raised its price target on Bath & Body Works shares from $48.00 to $50.00 and gave the company a “buy” rating in a Friday, November 18 research report. Finally, Morgan Stanley raised its price target on Bath & Body Works from $72.00 to $76.00 and gave the company an “overweight” rating in a Thursday, November 17 research report. One equity research analyst rated the stock with a sell rating, five gave the company a hold rating, thirteen issued a buy rating and one gave the company a high buy rating. According to MarketBeat.com, Bath & Body Works currently has a “Moderate Buy” consensus rating and an average target price of $51.52.

Company Profile Bath & Body Works

(Get a rating)

Bath & Body Works, Inc. is a specialty retailer and home of America’s Favorite Fragrances, offering a range of exclusive fragrances for body and home, including retail collections for Fine Fragrance Mist, Body Lotion and body cream, 3 wick candles, home fragrance diffusers and liquid hand soap.

See also

Want to see which other hedge funds hold BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Bath & Body Works, Inc. (NYSE: BBWIGet a rating).

Institutional ownership by quarter for Bath & Body Works (NYSE: BBWI)

This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected].

Before you consider Bath & Body Works, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market spreads…and that Bath & Body Works didn’t make the list.

While Bath & Body Works currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

7 stocks to buy and hold forever

Comments are closed.